Cargando…

Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic stroke

BACKGROUND: Stroke is one of the most common neurological diseases in the world and is clinically manifested by transient or permanent brain dysfunction. It has a high mortality and disability rate, which severely affects people's health and diminishes the quality of life. However, there is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Xiaoqi, Jian, Yujin, Ding, Shenghao, Zhou, Jianpo, Zheng, Xiaoli, Zhang, Huimin, Zhou, Butian, Zhuang, Canbin, Wan, Jieqing, Tong, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791134/
https://www.ncbi.nlm.nih.gov/pubmed/36527899
http://dx.doi.org/10.1016/j.ebiom.2022.104406
_version_ 1784859333345935360
author Hong, Xiaoqi
Jian, Yujin
Ding, Shenghao
Zhou, Jianpo
Zheng, Xiaoli
Zhang, Huimin
Zhou, Butian
Zhuang, Canbin
Wan, Jieqing
Tong, Xiaoping
author_facet Hong, Xiaoqi
Jian, Yujin
Ding, Shenghao
Zhou, Jianpo
Zheng, Xiaoli
Zhang, Huimin
Zhou, Butian
Zhuang, Canbin
Wan, Jieqing
Tong, Xiaoping
author_sort Hong, Xiaoqi
collection PubMed
description BACKGROUND: Stroke is one of the most common neurological diseases in the world and is clinically manifested by transient or permanent brain dysfunction. It has a high mortality and disability rate, which severely affects people's health and diminishes the quality of life. However, there is no efficient treatment that can be considered curative and there are other less well-known theories of pathogenesis. Therefore, it is imperative to gain a full understanding of the pathophysiology of ischemia and to seek new therapeutic strategies. METHODS: We first examined Kir4.1 channel and myelin based protein (MBP) expression in brain tissues from acute ischemic patients by Western blotting. We then established a transient ischemic mouse model (tMCAO) to conduct molecular, cell biological, transmission electron microscopy and pharmacokinetic studies, as well as in Kir4.1 cKO mice. Finally, neuroimaging and behavioral analyses were used to examine whether activation of Kir4.1 channel by luteolin could contribute to neuronal functional recovery in ischemic stroke. FINDINGS: In acute ischemic stroke patients, we first demonstrated that Kir4.1 ion channels were greatly impaired and a severe demyelination of axons occurred in ischemic infarction area of cerebral cortex in these patients. Further evidence showed that the deficits of Kir4.1 channels in NG2 glia led to the myelin loss of axons in a transient ischemic mouse model (tMCAO). Treating ischemic mice with a natural botanical extract, luteolin augmented Kir4.1 channel currents in NG2 glia and consequently promoted remyelination of axons, alleviated the infarction area and ultimately improved motor function in a series of behavioral tests. INTERPRETATION: Targeting Kir4.1 ion channels expressed in NG2 glial cells by luteolin treatment highlights an effective therapeutic strategy for a prompt brain functional recovery in ischemic stroke. FUNDING: This work was supported by grants from the Ministry of Science and Technology China Brain Initiative (2022ZD0204702, to X.T.), the 10.13039/100014717National Natural Science Foundation of China (82271466, 82171279, 31970904 and 31571063), the 10.13039/501100013285Program for Professor of Special Appointment (Eastern Scholar for Dr. X.T.) at Shanghai Institutions for Higher Learning (1510000084), Shanghai Pujiang Talent Award (15PJ1404600), 10.13039/501100003399Shanghai Municipal Science and Technology Major Project (2018SHZDZX05) and Shanghai Science and Technology Project (17411954000).
format Online
Article
Text
id pubmed-9791134
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97911342022-12-27 Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic stroke Hong, Xiaoqi Jian, Yujin Ding, Shenghao Zhou, Jianpo Zheng, Xiaoli Zhang, Huimin Zhou, Butian Zhuang, Canbin Wan, Jieqing Tong, Xiaoping eBioMedicine Articles BACKGROUND: Stroke is one of the most common neurological diseases in the world and is clinically manifested by transient or permanent brain dysfunction. It has a high mortality and disability rate, which severely affects people's health and diminishes the quality of life. However, there is no efficient treatment that can be considered curative and there are other less well-known theories of pathogenesis. Therefore, it is imperative to gain a full understanding of the pathophysiology of ischemia and to seek new therapeutic strategies. METHODS: We first examined Kir4.1 channel and myelin based protein (MBP) expression in brain tissues from acute ischemic patients by Western blotting. We then established a transient ischemic mouse model (tMCAO) to conduct molecular, cell biological, transmission electron microscopy and pharmacokinetic studies, as well as in Kir4.1 cKO mice. Finally, neuroimaging and behavioral analyses were used to examine whether activation of Kir4.1 channel by luteolin could contribute to neuronal functional recovery in ischemic stroke. FINDINGS: In acute ischemic stroke patients, we first demonstrated that Kir4.1 ion channels were greatly impaired and a severe demyelination of axons occurred in ischemic infarction area of cerebral cortex in these patients. Further evidence showed that the deficits of Kir4.1 channels in NG2 glia led to the myelin loss of axons in a transient ischemic mouse model (tMCAO). Treating ischemic mice with a natural botanical extract, luteolin augmented Kir4.1 channel currents in NG2 glia and consequently promoted remyelination of axons, alleviated the infarction area and ultimately improved motor function in a series of behavioral tests. INTERPRETATION: Targeting Kir4.1 ion channels expressed in NG2 glial cells by luteolin treatment highlights an effective therapeutic strategy for a prompt brain functional recovery in ischemic stroke. FUNDING: This work was supported by grants from the Ministry of Science and Technology China Brain Initiative (2022ZD0204702, to X.T.), the 10.13039/100014717National Natural Science Foundation of China (82271466, 82171279, 31970904 and 31571063), the 10.13039/501100013285Program for Professor of Special Appointment (Eastern Scholar for Dr. X.T.) at Shanghai Institutions for Higher Learning (1510000084), Shanghai Pujiang Talent Award (15PJ1404600), 10.13039/501100003399Shanghai Municipal Science and Technology Major Project (2018SHZDZX05) and Shanghai Science and Technology Project (17411954000). Elsevier 2022-12-15 /pmc/articles/PMC9791134/ /pubmed/36527899 http://dx.doi.org/10.1016/j.ebiom.2022.104406 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Hong, Xiaoqi
Jian, Yujin
Ding, Shenghao
Zhou, Jianpo
Zheng, Xiaoli
Zhang, Huimin
Zhou, Butian
Zhuang, Canbin
Wan, Jieqing
Tong, Xiaoping
Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic stroke
title Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic stroke
title_full Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic stroke
title_fullStr Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic stroke
title_full_unstemmed Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic stroke
title_short Kir4.1 channel activation in NG2 glia contributes to remyelination in ischemic stroke
title_sort kir4.1 channel activation in ng2 glia contributes to remyelination in ischemic stroke
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791134/
https://www.ncbi.nlm.nih.gov/pubmed/36527899
http://dx.doi.org/10.1016/j.ebiom.2022.104406
work_keys_str_mv AT hongxiaoqi kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke
AT jianyujin kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke
AT dingshenghao kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke
AT zhoujianpo kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke
AT zhengxiaoli kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke
AT zhanghuimin kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke
AT zhoubutian kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke
AT zhuangcanbin kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke
AT wanjieqing kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke
AT tongxiaoping kir41channelactivationinng2gliacontributestoremyelinationinischemicstroke